Cytek Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cytek Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18% to $193,015,000. Profit margin reached -6%. Total operating expenses were $137,271,000.
Profit Margin
| 2019 | 57.88M | -16.82M | -29.07% |
|---|---|---|---|
| 2020 | 92.83M | 19.41M | 20.91% |
| 2021 | 127.95M | 4.41M | 3.45% |
| 2022 | 164.03M | 2.57M | 1.57% |
| 2023 | 193.01M | -12.14M | -6.29% |
CTKB Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 193.01M | 164.03M | 127.95M | 92.83M | 57.88M |
Cost of revenue | 83.58M | 63.06M | 48.80M | 41.12M | 29.20M |
Gross profit | 109.42M | 100.97M | 79.14M | 51.71M | 28.67M |
Operating exp. | |||||
Research and development | 44.15M | 34.85M | 24.44M | 13.69M | 8.93M |
Selling and marketing | 49.14M | 33.23M | 24.71M | 14.98M | 10.24M |
Total operating expenses | 137.27M | 102.77M | 69.97M | 38.05M | 25.91M |
Operating income | -27.84M | -1.82M | 6.44M | 13.65M | 3.72M |
Other income (expenses), net | 12.13M | 3.08M | -499K | 771K | -20.02M |
Income before tax | -15.70M | 1.26M | 5.94M | 14.43M | -16.29M |
Income tax expense | -3.56M | -1.22M | 1.50M | -4.98M | 533K |
Net income | -12.14M | 2.57M | 4.41M | 19.41M | -16.82M |
Earnings per share | |||||
Basic EPS | -0.08 | 0.01 | 0.03 | 0.02 | -0.13 |
Diluted EPS | -0.08 | 0.01 | 0.03 | 0.02 | -0.13 |
| Data source | Data source | Data source |